Atlas Trials

A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies

Clinical trial NCT01204073 · COMPLETED

Trial details

NCT number
NCT01204073
Sponsor
Millennium Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Nonhematologic MalignanciesCarcinoma, Basal Cell
Start date
2010-10-01
Primary completion
2012-12-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.